|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> Dasotraline>> Market Analysis Reports |
Market Analysis Reports of Dasotraline |
|
Binge Eating Disorder - Pipeline Review, H1 2020 Binge Eating Disorder - Pipeline Review, H1 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Binge Eating Disorder - Pipeline Review, H1 2020, provides an overview of the Binge Eating Disorder (Central ... 2020 Attention Deficit Hyperactivity Disorder (ADHD) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs ... , CX717, brilaroxazine, SHX-009, SKL13865, dasotraline, SPN-810 (molindone hydrochloride), SPN ... 2020 Binge Eating Disorder Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs ... for Central Nervous System Disorders, dasotraline (SEP360-221), (Phentermine and topiramate ... Attention Deficit Hyperactivity Disorder (ADHD): Disease Insights and Market Forecasts to 2024 Delivery time for this report is 5 days “Attention Deficit Hyperactivity Disorder (ADHD): Disease Insights and Market Forecasts to 2024” report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Attention Deficit ... CNS Therapeutics: Market Research Report This report analyzes the worldwide markets for CNS Therapeutics in US$ Million by the following Product Groups: Anti-Alzheimer's, Anti-Parkinson's, Anti-Epilepsy, Pain Management, Anti-Psychotics, Anti-Depressants, and Others. The report provides separate ... Japan Pharma Outlook 2015: 2015 –Year to Watch Out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives The new pricing system adopted in Japan from April -2014 (Annexure 1) is a game changer initiative. It pains most of the companies - whether generic or innovator. The most of the companies are revalidating their domestic (and thus overseas) strategies to ... Adrenergic uptake inhibitors - Pipeline Insight, 2022 ... extended release Levomilnacipran Centanafadine Reboxetine Dasotraline Tapentadol intranasal NS 2359 OPC 64005 ... Attention Deficit Hyperactivity Disorder (ADHD): Pipeline Assessment and Insights Delivery time for this report is 2-3 days “Attention Deficit Hyperactivity Disorder (ADHD): Pipeline Assessment and Insights” report delivers an in-depth understanding of the disease, highlights all the pipeline products in different phases of development ... |